Sergio Traversa
Chief Executive Officer, Director at Relmada Therapeutics, Inc. (RLMD)
Sergio Traversa has filed 27 insider reports with the SEC since January 2021, as chief Executive Officer and director at Relmada Therapeutics, Inc. (RLMD). In the last 12 months Sergio Traversa bought $941K of stock on the open market. In the latest filing, on September 11, 2026, Sergio Traversa bought 200,000 shares of Relmada Therapeutics, Inc. (RLMD) for $828K at an average of $4.14.
- Filings
- 27
- Companies
- 1
- Bought on market
- $2.79M
- Sold on market
- $2.29M
Companies where Sergio Traversa is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | 1,500,000 | $2.79M | $2.29M | $1.98 | $2.855+44% | Sep 11, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 10, 2026+$828KRLMDChief Executive Officer Traversa Sergio bought $828,000 worth of shares (200,000 units at $4.14), increasing direct ownership by 15% to 1,500,000 unitsForm 4Open-market purchase
- Dec 15, 2025+$113KRLMDChief Executive Officer Traversa Sergio bought $113,300 worth of shares (27,500 units at $4.12), increasing direct ownership by 2% to 1,300,000 unitsForm 4Grant or awardOpen-market purchase
- Nov 5, 2025+$600KRLMDChief Executive Officer Traversa Sergio bought $599,500 worth of shares (272,500 units at $2.20), increasing direct ownership by 27% to 1,272,500 unitsForm 4Open-market purchase
- Aug 28, 2025+$178KRLMDChief Executive Officer Traversa Sergio bought $178,095 worth of shares (265,976 units at $0.67), increasing direct ownership by 36% to 1,000,000 unitsForm 4Open-market purchase
- Jun 26, 2025RLMDSEC Form 4 filed by Chief Executive Officer Traversa SergioForm 4Grant or award
- May 20, 2025+$175KRLMDChief Executive Officer Traversa Sergio bought $174,713 worth of shares (350,000 units at $0.50), increasing direct ownership by 91% to 734,024 unitsForm 4Open-market purchase
- Sep 11, 2024+$395KRLMDChief Executive Officer Traversa Sergio bought $395,115 worth of shares (140,000 units at $2.82), increasing direct ownership by 57% to 384,024 unitsForm 4Open-market purchase
- May 24, 2024RLMDSEC Form 4 filed by Traversa SergioForm 4Grant or awardOther acquisition or disposition
- Jan 31, 2024+$387KRLMDTraversa Sergio bought $386,738 worth of shares (100,000 units at $3.87), increasing direct ownership by 69% to 244,024 unitsForm 4Open-market purchase
- Dec 15, 2023RLMDSEC Form 4 filed by Traversa SergioForm 4Grant or award
- May 25, 2023RLMDSEC Form 4 filed by Traversa SergioForm 4Grant or award
- Sep 28, 2022RLMDSEC Form 5 filed by Traversa Sergio (Amendment)Form 5Gift
- Jul 8, 2021RLMDSEC Form 5 filed by Traversa SergioForm 5Gift
- Dec 16, 2022RLMDSEC Form 4 filed by Traversa SergioForm 4Other acquisition or disposition
- Dec 16, 2022RLMDSEC Form 4 filed by Traversa SergioForm 4Grant or award
- Dec 8, 2022+$116KRLMDSEC Form 4: Traversa Sergio bought $115,804 worth of shares (55,250 units at $2.10), increasing direct ownership by 62% to 144,024 unitsForm 4Open-market purchase
- Jul 1, 2022-$560KRLMDSEC Form 4: Traversa Sergio exercised 29,767 shares at a strike of $16.00 and sold $559,577 worth of shares (29,767 units at $18.80)Form 4Exercise or conversion of a derivativeOpen-market sale
- May 25, 2022RLMDSEC Form 4 filed by Traversa SergioForm 4Grant or award
- Dec 17, 2021RLMDSEC Form 4 filed by Traversa SergioForm 4Grant or award
- Mar 10, 2021-$355KRLMDSEC Form 4: Sergio Traversa exercised 10,000 units of Common Stock at a strike of $3.24 and sold $354,845 worth of Common Stock (10,000 units at $35.48)Form 4Exercise or conversion of a derivativeOpen-market sale
- Feb 24, 2021-$342KRLMDSEC Form 4: Sergio Traversa exercised 10,000 units of Common Stock at a strike of $3.24 and sold $342,392 worth of Common Stock (10,000 units at $34.24)Form 4Exercise or conversion of a derivativeOpen-market sale
- Feb 11, 2021-$51.2KRLMDSEC Form 4: Sergio Traversa exercised 1,446 units of Common Stock at a strike of $3.24 and sold $51,238 worth of Common Stock (1,446 units at $35.43)Form 4Exercise or conversion of a derivativeOpen-market sale
- Feb 10, 2021-$394KRLMDSEC Form 4: Sergio Traversa exercised 11,206 units of Common Stock at a strike of $3.24 and sold $394,085 worth of Common Stock (11,206 units at $35.17)Form 4Exercise or conversion of a derivativeOpen-market sale
- Feb 2, 2021RLMDSEC Form 4: Sergio Traversa exercised 13,281 units of Common Stock at a strike of $3.24, increasing ownership by 18% to 88,774 unitsForm 4Exercise or conversion of a derivative
- Feb 3, 2021-$115KRLMDSEC Form 4: Sergio Traversa exercised 3,278 units of Common Stock at a strike of $3.24 and sold $114,970 worth of Common Stock (3,278 units at $35.07), increasing ownership by 0.11% to 88,874 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Jan 27, 2021-$324KRLMDSEC Form 4: Sergio Traversa exercised 10,000 units of Common Stock at a strike of $3.24 and sold $323,914 worth of Common Stock (10,000 units at $32.39)Form 4Exercise or conversion of a derivativeOpen-market sale
- Jan 26, 2021-$144KRLMDSEC Form 4: Sergio Traversa exercised 4,070 units of Common Stock at a strike of $3.24 and sold $144,516 worth of Common Stock (4,070 units at $35.51)Form 4Exercise or conversion of a derivativeOpen-market sale
Compare Sergio Traversa with
- Sergio Traversa vs Maged Shenouda1 shared
- Sergio Traversa vs Chuck Ence1 shared
- Sergio Traversa vs Fabiana Fedeli1 shared
- Sergio Traversa vs John Glasspool1 shared
- Sergio Traversa vs Paul Edward Kelly1 shared
- Sergio Traversa vs Charles J Casamento1 shared
Other insiders at the same companies
- Maged ShenoudaRLMD
- Chuck EnceRLMD
- Fabiana FedeliRLMD
- John GlasspoolRLMD
- Paul Edward KellyRLMD
- Charles J CasamentoRLMD
Questions about Sergio Traversa
- What is Sergio Traversa's role at Relmada Therapeutics, Inc.?
- Sergio Traversa reports to the SEC as chief Executive Officer and director at Relmada Therapeutics, Inc. (RLMD), according to the latest filing on September 11, 2026.
- How many shares does Sergio Traversa own?
- After the latest filing that states it, Sergio Traversa directly owned 1,500,000 shares of Relmada Therapeutics, Inc. (RLMD). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Sergio Traversa bought or sold stock recently?
- The most recent open-market purchase was on September 10, 2026: bought 200,000 shares of Relmada Therapeutics, Inc. (RLMD) for $828K at an average of $4.14. The most recent open-market sale was on July 1, 2022: sold 29,767 shares of Relmada Therapeutics, Inc. (RLMD) for $560K at an average of $18.80.
- How do I get alerts when Sergio Traversa files?
- Follow Sergio Traversa on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Sergio Traversa filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Sergio Traversa (SEC CIK 0001565832). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2021 on. View on SEC EDGAR